Citation: | LI Yanjie, QIN Zhengliang, ZHANG Xinjiang. Relative factors of early neurological deterioration in patients with acute ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2020, 24(9): 6-9. DOI: 10.7619/jcmp.202009002 |
Wang D R, Liu J F, Liu M, et al. Patterns of stroke between university hospitals and nonuniversity hospitals in mainland China: prospective multicenter hospital-based registry study[J]. World Neurosurg, 2017, 98: 258-265.
|
Wang W Z, Jiang B, Sun H X, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults[J]. Circulation, 2017, 135(8): 759-771.
|
杨姗姗, 王建华, 何耀, 等. 老年人群缺血性脑卒中与血脂异常的关系[J]. 中华高血压杂志, 2018, 26(4): 400-403.
|
Helleberg B H, Ellekjaer H, Rohweder G, et al. Mechanisms, predictors and clinical impact of early neurological deterioration: the protocol of the Trondheim early neurological deterioration study[J]. BMC Neurol, 2014, 14: 201-207.
|
Yi X Y, Wang C, Liu P, et al. Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population[J]. J Neurol, 2016, 263(8): 1612-1619.
|
Roy-O'reilly M, McCullough L D. Sex differences in stroke: The contribution of coagulation[J]. Exp Neurol, 2014, 259: 16-27.
|
Kwah L K, Diong J. National institutes of health stroke scale(NIHSS)[J]. J Physiother, 2014, 60(1): 61-67.
|
Miyamoto N, Tanaka Y, Ueno Y, et al. Demographic, clinical, and radiologic predictors of neurologic deterioration in patients with acute ischemic stroke[J]. J Stroke Cerebrovasc Dis, 2013, 22(3): 205-210.
|
Kjaergaard A D, Johansen J S, Bojesen S E, et al. Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population[J]. Stroke, 2015, 46(2): 329-335.
|
Lee S J, Lee D G. Distribution of atherosclerotic Stenosis determining early neurologic deterioration in acute ischemic stroke[J]. PLoS One, 2017, 12(9): e0185314.
|
Xu T, Ke K F. C-reactive protein and ischemic stroke risk in general population: a dose-response meta-analysis of prospective studies[J]. Int J Cardiol, 2015, 190: 264-267.
|
魏东, 杨宗军, 王晓晶. 急性脑梗死患者血清超敏C-反应蛋白和纤维蛋白原检测的临床意义[J]. 山东医药, 2018, 58(33): 77-79.
|
姚涛, 任明山, 李淮玉. 缺血性脑卒中急性期超敏C-反应蛋白水平变化与进展性卒中的相关性[J]. 实用医学杂志, 2016, 32(5): 735-738.
|
Catena C, Colussi G, Url-Michitsch M, et al. Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension[J]. J Am Soc Hypertens, 2015, 9(3): 167-175.
|
岳伟, 吴昊, 石志鸿, 等. 血浆同型半胱氨酸水平与急性缺血性脑卒中患者的卒中复发及死亡关系的研究[J]. 中华神经医学杂志, 2016, 15(7): 654-659.
|
王莉, 沈娟, 陈从新, 等. 血液同型半胱氨酸水平与不同亚型脑卒中相关性的Meta分析[J]. 中国老年学杂志, 2018, 38(9): 2052-2055.
|
Huang X, Li Y B, Li P, et al. Association between percent decline in serum total homocysteine and risk of first stroke[J]. Neurology, 2017, 89(20): 2101-2107.
|